Healthcare provider profile · identity verified

Kevin Ly

Family Practice · BLOOMSBURG, PA · NPI 1720564289

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	834	246
Lisinopril	Lisinopril	492	175
Omeprazole	Omeprazole	444	121
Amlodipine Besylate	Amlodipine Besylate	353	106
Levothyroxine Sodium	Levothyroxine Sodium	348	95
Metoprolol Succinate	Metoprolol Succinate	274	82
Losartan Potassium	Losartan Potassium	251	84
Gabapentin	Gabapentin	240	77
Rosuvastatin Calcium	Rosuvastatin Calcium	185	71
Hydrochlorothiazide	Hydrochlorothiazide	183	60
Furosemide	Furosemide	182	56
Metoprolol Tartrate	Metoprolol Tartrate	167	55
Metformin Hcl Er	Metformin Hcl	157	49
Metformin Hcl	Metformin Hcl	153	51
Tamsulosin Hcl	Tamsulosin Hcl	147	46
Simvastatin	Simvastatin	144	48
Pantoprazole Sodium	Pantoprazole Sodium	140	42
Fluticasone Propionate	Fluticasone Propionate	136	63
Warfarin Sodium	Warfarin Sodium	131	49
Albuterol Sulfate Hfa	Albuterol Sulfate	125	51
Potassium Chloride	Potassium Chloride	116	33
Jardiance	Empagliflozin	112	32
Montelukast Sodium	Montelukast Sodium	112	36
Alendronate Sodium	Alendronate Sodium	107	27
Eliquis	Apixaban	104	30
Sertraline Hcl	Sertraline Hcl	104	37
Ozempic	Semaglutide	103	29
Ezetimibe	Ezetimibe	101	28
Atenolol	Atenolol	98	35
Duloxetine Hcl	Duloxetine Hcl	91	27
Escitalopram Oxalate	Escitalopram Oxalate	89	29
Famotidine	Famotidine	81	18
Allopurinol	Allopurinol	78	20
Clopidogrel	Clopidogrel Bisulfate	75	28
Pravastatin Sodium	Pravastatin Sodium	75	21
Carvedilol	Carvedilol	64	16
Trazodone Hcl	Trazodone Hcl	62	17
Hydroxyzine Hcl	Hydroxyzine Hcl	60	15
Venlafaxine Hcl Er	Venlafaxine Hcl	56	16
Glipizide Er	Glipizide	52	16
Meloxicam	Meloxicam	51	17
Fenofibrate	Fenofibrate Nanocrystallized	49	12
Tramadol Hcl	Tramadol Hcl	48	17
Bupropion Xl	Bupropion Hcl	47	suppressed
Buspirone Hcl	Buspirone Hcl	47	20
Fluoxetine Hcl	Fluoxetine Hcl	47	11
Quetiapine Fumarate	Quetiapine Fumarate	44	suppressed
Spironolactone	Spironolactone	44	12
Ropinirole Hcl	Ropinirole Hcl	40	12
Tizanidine Hcl	Tizanidine Hcl	39	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	38	18
Pregabalin	Pregabalin	37	17
Lovastatin	Lovastatin	36	15
Mounjaro	Tirzepatide	35	suppressed
Baclofen	Baclofen	34	18
Amitriptyline Hcl	Amitriptyline Hcl	33	suppressed
Mirtazapine	Mirtazapine	33	suppressed
Topiramate	Topiramate	33	suppressed
Citalopram Hbr	Citalopram Hydrobromide	32	11
Torsemide	Torsemide	32	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	31	suppressed
Alprazolam	Alprazolam	30	suppressed
Lorazepam	Lorazepam	30	14
Nitroglycerin	Nitroglycerin	30	19
Chlorthalidone	Chlorthalidone	29	12
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	29	13
Isosorbide Mononitrate Er	Isosorbide Mononitrate	28	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	27	suppressed
Levetiracetam	Levetiracetam	27	suppressed
Ventolin Hfa	Albuterol Sulfate	27	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	25	suppressed
Calcitriol	Calcitriol	24	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	24	suppressed
Lamotrigine	Lamotrigine	24	suppressed
Breo Ellipta	Fluticasone/Vilanterol	23	suppressed
Prednisone	Prednisone	23	13
Diclofenac Sodium	Diclofenac Sodium	22	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	22	suppressed
Incruse Ellipta	Umeclidinium Bromide	22	suppressed
Nystatin	Nystatin	22	13
Sucralfate	Sucralfate	22	suppressed
Azelastine Hcl	Azelastine Hcl	21	suppressed
Glipizide	Glipizide	21	suppressed
Naltrexone Hcl	Naltrexone Hcl	21	suppressed
Novolog Flexpen	Insulin Aspart	21	13
Olanzapine	Olanzapine	21	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	21	suppressed
Risperidone	Risperidone	20	suppressed
Benztropine Mesylate	Benztropine Mesylate	19	suppressed
Finasteride	Finasteride	19	suppressed
Propranolol Hcl	Propranolol Hcl	19	suppressed
Aripiprazole	Aripiprazole	18	suppressed
Clonazepam	Clonazepam	18	suppressed
Oxycodone Hcl	Oxycodone Hcl	18	suppressed
Repaglinide	Repaglinide	18	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	18	12
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	18	suppressed
Vascepa	Icosapent Ethyl	18	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	17	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	17	suppressed
Donepezil Hcl	Donepezil Hcl	17	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	17	suppressed
Ketoconazole	Ketoconazole	17	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	17	suppressed
Valacyclovir	Valacyclovir Hcl	17	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	16	suppressed
Jantoven	Warfarin Sodium	16	suppressed
Meclizine Hcl	Meclizine Hcl	16	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	16	suppressed
Clonidine Hcl	Clonidine Hcl	15	suppressed
Divalproex Sodium	Divalproex Sodium	15	suppressed
Ondansetron Hcl	Ondansetron Hcl	15	suppressed
Paroxetine Hcl	Paroxetine Hcl	15	suppressed
Xarelto	Rivaroxaban	15	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	14	suppressed
Benazepril Hcl	Benazepril Hcl	14	suppressed
Bupropion Hcl Sr	Bupropion Hcl	14	suppressed
Cimetidine	Cimetidine	14	suppressed
Enalapril Maleate	Enalapril Maleate	14	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	14	suppressed
Humulin R U-500 Kwikpen	Insulin Regular, Human	14	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	14	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	14	suppressed
Trulicity	Dulaglutide	14	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	13	suppressed
Enulose	Lactulose	13	suppressed
Memantine Hcl	Memantine Hcl	13	suppressed
Methocarbamol	Methocarbamol	13	suppressed
Tradjenta	Linagliptin	13	suppressed
Amoxicillin	Amoxicillin	12	suppressed
Celecoxib	Celecoxib	12	suppressed
Diazepam	Diazepam	12	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	12	suppressed
Felodipine Er	Felodipine	12	suppressed
Hydralazine Hcl	Hydralazine Hcl	12	suppressed
Methadone Hcl	Methadone Hcl	12	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	12	11
Olmesartan Medoxomil	Olmesartan Medoxomil	12	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	12	suppressed
Raloxifene Hcl	Raloxifene Hcl	12	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	12	suppressed
Admelog Solostar	Insulin Lispro	11	suppressed
Amiodarone Hcl	Amiodarone Hcl	11	suppressed
Cephalexin	Cephalexin	11	11
Fentanyl	Fentanyl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error